Home › Diffuse Large B-Cell Lymphoma › Wisconsin › La Crosse
Diffuse Large B-Cell Lymphoma clinical trials in La Crosse, WI
4 studies for Diffuse Large B-Cell Lymphoma are looking for participants at sites in and around La Crosse (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
RecruitingPhase 3
- Gunderson Health System ( Site 9563), La Crosse
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
RecruitingPhase 2
- Gundersen Lutheran Medical Center, La Crosse
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
RecruitingPhase 2
- Gundersen Lutheran Medical Center, La Crosse
Golcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma Before CAR T-cell Therapy
RecruitingPhase 2
- Mayo Clinic Health System-Franciscan Healthcare, La Crosse
Diffuse Large B-Cell Lymphoma trials in other cities
- New York City, NY20 studies
- Baldwin Park, CA19 studies
- Los Angeles, CA18 studies
- Houston, TX18 studies
- Chicago, IL18 studies
- Milwaukee, WI17 studies
- Nashville, TN17 studies
- Boston, MA17 studies
- Philadelphia, PA15 studies
- Durham, NC15 studies
- Portland, OR15 studies
- Cleveland, OH13 studies
Other studies in La Crosse
- Non-Small Cell Lung Cancer12 studies
- Lung Cancer10 studies
- Acute Myeloid Leukemia6 studies
- Breast Cancer5 studies
- Multiple Myeloma4 studies
- Cancer (all types)3 studies
- Ovarian Cancer3 studies
- Laryngeal Cancer3 studies
- Oral Cancer3 studies
- Endometrial Cancer3 studies
- Head and Neck Squamous Cell Carcinoma3 studies
- Melanoma3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.